Involvement of the rabies virus phosphoprotein gene in neuroinvasiveness

Journal of Virology

Volumn 87, Issue 22, 2013, Pages 12327-12338

  Yamaoka, Satoko ^a   Ito, Naoto ^a,b   Ohka, Seii ^c,f   Kaneda, Shohei ^d,e   Nakamura, Hiroko ^d,e   Agari, Takahiro ^b   Masatani, Tatsunori ^a,g   Nakagawa, Keisuke ^a   Okada, Kazuma ^a   Okadera, Kota ^a   Mitake, Hiromichi ^a   Fujii, Teruo ^d,e   Sugiyama, Makoto ^a,b  

^a Graduate School of Health Sciences   (Japan)

^b Department of Chemistry   (Japan)

^c GIFU UNIVERSITY   (Japan)

^d INSTITUTE OF INDUSTRIAL SCIENCE   (Japan)

^e JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^f TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^g OBIHIRO UNIVERSITY OF AGRICULTURE AND VETERINARY MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; PHOSPHOPROTEIN; 2',5' OLIGOADENYLATE SYNTHETASE; INTERFERON; INTERFERON REGULATORY FACTOR 1; MESSENGER RNA; MYXOVIRUS RESISTANCE PROTEIN; P PHOSPHOPROTEIN, RABIES VIRUS; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASYMPTOMATIC INFECTION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IFN BETA GENE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; MUSCLE CELL; NONHUMAN; P GENE; PERIPHERAL NERVE; PRIORITY JOURNAL; RABIES VIRUS; VIRUS GENE; VIRUS REPLICATION; VIRUS STRAIN; VIRUS VIRULENCE; ANIMAL; CELL CULTURE; GENETICS; METABOLISM; MYOBLAST; NEUROBLASTOMA; PATHOGENICITY; PATHOLOGY; RABIES; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHABDOMYOSARCOMA; VIROLOGY; VIRULENCE; WESTERN BLOTTING;

ANIMALIA; MUS; RABIES VIRUS;

2',5'-OLIGOADENYLATE SYNTHETASE; ANIMALS; BLOTTING, WESTERN; CELLS, CULTURED; FEMALE; INTERFERON REGULATORY FACTOR-1; INTERFERONS; MICE; MUSCLE CELLS; MYOBLASTS; MYXOVIRUS RESISTANCE PROTEINS; NEUROBLASTOMA; PERIPHERAL NERVES; PHOSPHOPROTEINS; RABIES; RABIES VIRUS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RHABDOMYOSARCOMA; RNA, MESSENGER; VIRAL STRUCTURAL PROTEINS; VIRULENCE; VIRUS REPLICATION;

EID: 84886295821     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02132-13     Document Type: Article

References (51)

1. Jackson AC. 2007. Pathogenesis, p 341-381. In Jackson AC, WunnerWH (ed), Rabies, 2nd ed. Academic Press, London, United Kingdom.
2. Knobel DL, Cleaveland S, Coleman PG, Fevre EM, Meltzer MI, Miranda ME, Shaw A, Zinsstag J, Meslin FX. 2005. Re-evaluating the burden of rabies in Africa and Asia. Bull. World Health Organ. 83:360-368.
3. Dietzschold B, Wiktor TJ, Trojanowski JQ, Macfarlan RI, Wunner WH, Torres-Anjel MJ, Koprowski H. 1985. Differences in cell-to-cell spread of pathogenic and apathogenic rabies virus in vivo and in vitro. J. Virol. 56:12-18.
4. Ito N, Moseley GW, Blondel D, Shimizu K, Rowe CL, Ito Y, Masatani T, Nakagawa K, Jans DA, Sugiyama M. 2010. Role of interferon antagonist activity of rabies virus phosphoprotein in viral pathogenicity. J. Virol. 84:6699-6710.
5. Masatani T, Ito N, Shimizu K, Ito Y, Nakagawa K, Sawaki Y, Koyama H, Sugiyama M. 2010. Rabies virus nucleoprotein functions to evade activation of the RIG-I-mediated antiviral response. J. Virol. 84:4002-4012.
6. Prehaud C, Lay S, Dietzschold B, Lafon M. 2003. Glycoprotein of nonpathogenic rabies viruses is a key determinant of human cell apoptosis. J. Virol. 77:10537-10547.
7. Charlton KM, Casey GA. 1979. Experimental rabies in skunks: immunofluorescence light and electron microscopic studies. Lab. Invest. 41:36-44.
8. Charlton KM, Nadin-Davis S, Casey GA, Wandeler AI. 1997. The long incubation period in rabies: delayed progression of infection in muscle at the site of exposure. Acta Neuropathol. 94:73-77.
9. Murphy FA, Bauer SP, Harrison AK, Winn WC, Jr. 1973. Comparative pathogenesis of rabies and rabies-like viruses. Viral infection and transit from inoculation site to the central nervous system. Lab. Invest. 28:361-376.
10. Park CH, Kondo M, Inoue S, Noguchi A, Oyamada T, Yoshikawa H, Yamada A. 2006. The histopathogenesis of paralytic rabies in six-weekold C57BL/6J mice following inoculation of the CVS-11 strain into the right triceps surae muscle. J. Vet. Med. Sci. 68:589-595.
11. Coulon P, Derbin C, Kucera P, Lafay F, Prehaud C, Flamand A. 1989. Invasion of the peripheral nervous systems of adult mice by the CVS strain of rabies virus and its avirulent derivative AvO1. J. Virol. 63:3550-3554.
12. Shankar V, Dietzschold B, Koprowski H. 1991. Direct entry of rabies virus into the central nervous system without prior local replication. J. Virol. 65:2736-2738.
13. Watson HD, Tignor GH, Smith AL. 1981. Entry of rabies virus into the peripheral nerves of mice. J. Gen. Virol. 56:372-382.
14. Wunner WH. 2007. Rabies virus, p 23-68. In Jackson AC, Wunner WH (ed), Rabies, 2nd ed. Academic Press, London, United Kingdom.
15. Blondel D, Regad T, Poisson N, Pavie B, Harper F, PandolfiPP, De The H, Chelbi-Alix MK. 2002. Rabies virus P and small P products interact directly with PML and reorganize PML nuclear bodies. Oncogene 21: 7957-7970.
16. Brzózka K, Finke S, Conzelmann KK. 2005. Identification of the rabies virus alpha/beta interferon antagonist: phosphoprotein P interferes with phosphorylation of interferon regulatory factor 3. J. Virol. 79:7673-7681.
17. Brzózka K, Finke S, Conzelmann KK. 2006. Inhibition of interferon signaling by rabies virus phosphoprotein P: activation-dependent binding of STAT1 and STAT2. J. Virol. 80:2675-2683.
18. Moseley GW, Lahaye X, Roth DM, Oksayan S, Filmer RP, Rowe CL, Blondel D, Jans DA. 2009. Dual modes of rabies P-protein association with microtubules: a novel strategy to suppress the antiviral response. J. Cell Sci. 122:3652-3662.
19. Rieder M, Brzózka K, Pfaller CK, Cox JH, Stitz L, Conzelmann KK. 2011. Genetic dissection of interferon-antagonistic functions of rabies virus phosphoprotein: inhibition of interferon regulatory factor 3 activation is important for pathogenicity. J. Virol. 85:842-852.
20. Vidy A, Chelbi-Alix M, Blondel D. 2005. Rabies virus P protein interacts with STAT1 and inhibits interferon signal transduction pathways. J. Virol. 79:14411-14420.
21. Vidy A, Bougrini JEL, Chelbi-Alix MK, Blondel D. 2007. The nucleocytoplasmic rabies virus P protein counteracts interferon signaling by inhibiting both nuclear accumulation and DNA binding of STAT1. J. Virol. 81:4255-4263.
22. Prehaud C, Coulon P, LaFay F, Thiers C, Flamand A. 1988. Antigenic site II of the rabies virus glycoprotein: structure and role in viral virulence. J. Virol. 62:1-7.
23. Mazarakis ND, Azzouz M, Rohll JB, Ellard FM, Wilkes FJ, Olsen AL, Carter EE, Barber RD, Baban DF, Kingsman SM, Kingsman AJ, O'Malley K, Mitrophanous KA. 2001. Rabies virus glycoprotein pseudotyping of lentiviral vectors enables retrograde axonal transport and access to the nervous system after peripheral delivery. Hum. Mol. Genet. 10:2109-2121.
24. Mentis GZ, Gravell M, Hamilton R, Shneider NA, O'Donovan MJ, Schubert M. 2006. Transduction of motor neurons and muscle fibers by intramuscular injection of HIV-1-based vectors pseudotyped with select rabies virus glycoproteins. J. Neurosci. Methods 157:208-217.
25. Faber M, Pulmanausahakul R, Nagao K, Prosniak M, Rice AB, Koprowski H, Schnell MJ, Dietzschold B. 2004. Identification of viral genomic elements responsible for rabies virus neuroinvasiveness. Proc. Natl. Acad. Sci. U. S. A. 101:16328-16332.
26. Morimoto K, Foley HD, McGettigan JP, Schnell MJ, Dietzschold B. 2000. Reinvestigation of the role of the rabies virus glycoprotein in viral pathogenesis using a reverse genetics approach. J. Neurovirol. 6:373-381.
27. Pulmanausahakul R, Li J, Schnell MJ, Dietzschold B. 2008. The glycoprotein and the matrix protein of rabies virus affect pathogenicity by regulating viral replication and facilitating cell-to-cell spread. J. Virol. 82: 2330-2338.
28. Virojanapirom P, Khawplod P, Sawangvaree A, Wacharapluesadee S, Hemachudha T, Yamada K, Morimoto K, Nishizono A. 2012. Molecular analysis of the mutational effects of Thai street rabies virus with increased virulence in mice after passages in the BHK cell line. Arch. Virol. 157: 2201-2205.
29. Yamada K, Park CH, Noguchi K, Kojima D, Kubo T, Komiya N, Matsumoto T, Mitui MT, Ahmed K, Morimoto K, Inoue S, Nishizono A. 2012. Serial passage of a street rabies virus in mouse neuroblastoma cells resulted in attenuation: potential role of the additional N-glycosylation of a viral glycoprotein in the reduced pathogenicity of street rabies virus. Virus Res. 165:34-45.
30. Shimizu K, Ito N, Mita T, Yamada K, Hosokawa-Muto J, Sugiyama M, Minamoto N. 2007. Involvement of nucleoprotein, phosphoprotein, and matrix protein genes of rabies virus in virulence for adult mice. Virus Res. 123:154-160.
31. Yamada K, Ito N, Takayama-Ito M, Sugiyama M, Minamoto N. 2006. Multigenic relation to the attenuation of rabies virus. Microbiol. Immunol. 50:25-32.
32. Ito N, Takayama-Ito M, Yamada K, Hosokawa J, Sugiyama M, Minamoto N. 2003. Improved recovery of rabies virus from cloned cDNA using a vaccinia virus-free reverse genetics system. Microbiol. Immunol. 47:613-617.
33. Minamoto N, Tanaka H, Hishida M, Goto H, Ito H, Naruse S, Yamamoto K, Sugiyama M, Kinjo T, Mannen K, Mifune K. 1994. Linear and conformation-dependent antigenic sites on the nucleoprotein of rabies virus. Microbiol. Immunol. 38:449-455.
34. Taylor AM, Blurton-Jones M, Rhee SW, Cribbs DH, Cotman CW, Jeon NL. 2005. A microfluidic culture platform for CNS axonal injury, regeneration and transport. Nat. Methods 2:599-605.
35. Park JW, Vahidi B, Taylor AM, Rhee SW, Jeon NL. 2006. Microfluidic culture platform for neuroscience research. Nat. Protoc. 1:2128-2136.
36. Arce V, Garces A, de Bovis B, Filippi P, Henderson C, Pettmann B, deLapeyriere O. 1999. Cardiotrophin-1 requires LIFRbeta to promote survival of mouse motoneurons purified by a novel technique. J. Neurosci. Res. 55:119-126.
37. Guo X, Das M, Rumsey J, Gonzalez M, Stancescu M, Hickman J. 2010. Neuromuscular junction formation between human stem-cell-derived motoneurons and rat skeletal muscle in a defined system. Tissue Eng. 16:1347-1355.
38. Klingen Y, Conzelmann KK, Finke S. 2008. Double-labeled rabies virus: live tracking of enveloped virus transport. J. Virol. 82:237-245.
39. Campenot RB, MacInnis BL. 2004. Retrograde transport of neurotrophins: fact and function. J. Neurobiol. 58:217-229.
40. MacInnis BL, Campenot RB. 2002. Retrograde support of neuronal survival without retrograde transport of nerve growth factor. Science 295: 1536-1539.
41. Yang IH, Siddique R, Hosmane S, Thakor N, Hoke A. 2009. Compartmentalized microfluidic culture platform to study mechanism of paclitaxel-induced axonal degeneration. Exp. Neurol. 218:124-128.
42. Marker DF, Puccini JM, Mockus TE, Barbieri J, Lu SM, Gelbard HA. 2012. LRRK2 kinase inhibition prevents pathological microglial phagocytosis in response to HIV-1 Tat protein. J. Neuroinflammation 9:261. doi: 10.1186/1742-2094-9-261.
43. Liu WW, Goodhouse J, Jeon NL, Enquist LW. 2008. A microfluidic chamber for analysis of neuron-to-cell spread and axonal transport of an alphaherpesvirus. PLoS One 3:e2382. doi:10.1371/journal.pone.0002382.
44. Markus A, Grigoryan S, Sloutskin A, Yee MB, Zhu H, Yang IH, Thakor NV, Sarid R, Kinchington PR, Goldstein RS. 2011. Varicella-zoster virus (VZV) infection of neurons derived from human embryonic stem cells: direct demonstration of axonal infection, transport of VZV, and productive neuronal infection. J. Virol. 85:6220-6233.
45. Murphy FA, Bauer SP. 1974. Early street rabies virus infection in striated muscle and later progression to the central nervous system. Intervirology 3:256-268.
46. Baer GM, Shantha TR, Bourne GH. 1968. The pathogenesis of street rabies virus in rats. Bull. World Health Organ. 38:119-125.
47. Johnson RT. 1965. Experimental rabies. Studies of cellular vulnerability and pathogenesis using fluorescent antibody staining. J. Neuropathol. Exp. Neurol. 24:662-674.
48. Randall RE, Goodbourn S. 2008. Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J. Gen. Virol. 89:1-47.
49. Emeny JM, Morgan MJ. 1979. Regulation of the interferon system: evidence that Vero cells have a genetic defect in interferon production. J. Gen. Virol. 43:247-252.
50. Baer GM, Moore SA, Shaddock JH, Levy HB. 1979. An effective rabies treatment in exposed monkeys: a single dose of interferon inducer and vaccine. Bull. World Health Organ. 57:807-813.
51. Baer GM, Shaddock JH, Moore SA, Yager PA, Baron SS, Levy HB. 1977. Successful prophylaxis against rabies in mice and Rhesus monkeys: the interferon system and vaccine. J. Infect. Dis. 136:286-291.